• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性高胆固醇血症的串联筛查:一项试点研究对国家筛查计划的启示

Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes.

作者信息

Marks D, Thorogood M, Neil S M, Humphries S E, Neil H A W

机构信息

London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK.

出版信息

J Med Screen. 2006;13(3):156-9. doi: 10.1258/096914106778440617.

DOI:10.1258/096914106778440617
PMID:17007658
Abstract

OBJECTIVES

To determine what proportion of cases of heterozygous familial hypercholesterolaemia would be identified by cascade screening conducted by a specialist hospital clinic, and by how much this would increase the prevalence of diagnosed cases.

SETTING

Hospital clinic serving a population of 605,900 in Oxfordshire, UK.

METHODS

A specialist nurse obtained details of living first-degree relatives from 227 adult patients with heterozygous familial hypercholesterolaemia currently or previously attending Oxford lipid clinic after excluding 79 adults without relatives living in Oxfordshire and 48 children. Index cases were asked to invite relatives resident in Oxfordshire for testing.

RESULTS

A total of 227 index cases had 1075 first-degree relatives, including 442 adults and 117 children aged < 18 years resident in Oxfordshire. We excluded 171 previously screened adults and 46 for other reasons. Among 225 eligible adult relatives, 28 responders (12%) planned to consult their general practitioner and 52 (23%) attended the clinic for testing. Parents of 113 children (97%) wanted them tested. The positive diagnostic rate was 29% (15/52) in adults and 32% (36/113) in children. Screening increased prevalence by 14.4%, from 0.58/1000 (95% confidence intervals [CI] 0.52-0.65) to 0.67/1000 (95% CI 0.60-0.73), representing 33.5% of predicted cases.

CONCLUSIONS

Cascade screening conducted by a specialist hospital clinic within its population catchment area did not substantially increase the prevalence of diagnosed familial hypercholesterolaemia. To maximize response rates, clinic staff need to approach relatives directly. Validated age, sex and country-specific diagnostic criteria should be defined, possibly with access to DNA-based tests, to help resolve diagnostic uncertainty.

摘要

目的

确定专科医院门诊进行的级联筛查能够识别出多大比例的杂合子家族性高胆固醇血症病例,以及这将使确诊病例的患病率提高多少。

背景

为英国牛津郡605,900人口提供服务的医院门诊。

方法

一名专科护士从227名目前或曾经在牛津血脂门诊就诊的成年杂合子家族性高胆固醇血症患者那里获取了在世一级亲属的详细信息,排除了79名在牛津郡没有亲属的成年人和48名儿童。索引病例被要求邀请居住在牛津郡的亲属前来检测。

结果

总共227例索引病例有1075名一级亲属,其中包括442名成年人和117名居住在牛津郡的18岁以下儿童。我们排除了171名之前已接受筛查的成年人以及46名因其他原因被排除的人。在225名符合条件的成年亲属中,28名(12%)计划咨询他们的全科医生,52名(23%)到门诊进行检测。113名儿童的父母中97%希望为他们进行检测。成年人的阳性诊断率为29%(15/52),儿童为32%(36/113)。筛查使患病率提高了14.4%,从0.58/1000(95%置信区间[CI]0.52 - 0.65)提高到0.67/1000(95%CI 0.60 - 0.73),占预测病例的33.5%。

结论

专科医院门诊在其服务区域内进行的级联筛查并未显著提高确诊家族性高胆固醇血症的患病率。为了使响应率最大化,门诊工作人员需要直接联系亲属。应定义经过验证的年龄、性别和特定国家的诊断标准,可能需要借助基于DNA的检测,以帮助解决诊断不确定性问题。

相似文献

1
Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes.家族性高胆固醇血症的串联筛查:一项试点研究对国家筛查计划的启示
J Med Screen. 2006;13(3):156-9. doi: 10.1258/096914106778440617.
2
Family tracing to identify patients with familial hypercholesterolaemia: the second audit of the Department of Health Familial Hypercholesterolaemia Cascade Testing Project.通过家族追踪识别家族性高胆固醇血症患者:卫生部家族性高胆固醇血症级联检测项目的第二次审计
Ann Clin Biochem. 2009 Jan;46(Pt 1):24-32. doi: 10.1258/acb.2008.008094. Epub 2008 Nov 21.
3
Integration of child-parent screening and cascade testing for familial hypercholesterolaemia.儿童-父母联合筛查与家族性高胆固醇血症级联筛查的整合。
J Med Screen. 2019 Jun;26(2):71-75. doi: 10.1177/0969141318796856. Epub 2018 Oct 14.
4
Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemia.将专家脂质服务的提供与家族性高胆固醇血症的级联检测相结合。
Curr Opin Lipidol. 2010 Aug;21(4):366-71. doi: 10.1097/MOL.0b013e32833c14e2.
5
Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands.荷兰家族性高胆固醇血症前5年筛查情况回顾。
Lancet. 2001 Jan 20;357(9251):165-8. doi: 10.1016/S0140-6736(00)03587-X.
6
Screening for familial hypercholesterolaemia.家族性高胆固醇血症筛查。
Pathology. 2012 Feb;44(2):122-8. doi: 10.1097/PAT.0b013e32834efa07.
7
Importance of early recognition of heterozygous familial hypercholesterolaemia.早期识别杂合子家族性高胆固醇血症的重要性。
Curr Opin Lipidol. 2015 Aug;26(4):298-303. doi: 10.1097/MOL.0000000000000196.
8
[A family-based strategy for diagnosing familial hypercholesterolemia].
Tidsskr Nor Laegeforen. 2004 May 6;124(9):1228-9.
9
The detection of heterozygous familial hypercholesterolemia in Ireland.爱尔兰杂合子家族性高胆固醇血症的检测。
Adv Ther. 2012 May;29(5):456-63. doi: 10.1007/s12325-012-0021-0. Epub 2012 May 17.
10
Are patients with familial hypercholesterolaemia well managed in lipid clinics? An audit of eleven clinics from the Department of Health Familial Hypercholesterolaemia Cascade Testing project.家族性高胆固醇血症患者在血脂诊所得到妥善管理了吗?对来自卫生部家族性高胆固醇血症级联检测项目的11家诊所的审计。
Ann Clin Biochem. 2008 Mar;45(Pt 2):199-205. doi: 10.1258/acb.2007.007078.

引用本文的文献

1
Public perspectives on healthcare professional-directed communication of hereditary genetic risks: a mixed-method systematic review.公众对医疗保健专业人员指导下的遗传性基因风险沟通的看法:一项混合方法的系统评价
Eur J Hum Genet. 2025 Feb 3. doi: 10.1038/s41431-025-01790-4.
2
Patients' perspectives regarding health professionals contacting their relatives about genetic risk directly (with patient consent).患者对于医疗专业人员在获得患者同意后直接联系其亲属告知遗传风险的看法。
Eur J Hum Genet. 2025 Apr;33(4):485-495. doi: 10.1038/s41431-024-01764-y. Epub 2024 Dec 17.
3
Health professionals contacting patients' relatives directly about genetic risk (with patient consent): current clinical practice and perspectives.
在获得患者同意的情况下,医疗专业人员直接联系患者亲属告知基因风险:当前临床实践与观点。
Eur J Hum Genet. 2025 Apr;33(4):476-484. doi: 10.1038/s41431-024-01730-8. Epub 2024 Dec 19.
4
Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis.替代级联检测方案用于识别和管理家族性高胆固醇血症患者:系统评价、定性研究和成本效益分析。
Health Technol Assess. 2023 Oct;27(16):1-140. doi: 10.3310/CTMD0148.
5
Privacy Implications of Contacting the At-Risk Relatives of Patients with Medically Actionable Genetic Predisposition, with Patient Consent: A Hypothetical Australian Case Study.经患者同意后联系具有医学可干预遗传易感性患者的高危亲属所涉及的隐私问题:一项澳大利亚的假设性案例研究
BioTech (Basel). 2023 Jun 2;12(2):45. doi: 10.3390/biotech12020045.
6
Direct notification by health professionals of relatives at-risk of genetic conditions (with patient consent): views of the Australian public.卫生专业人员直接通知有遗传疾病风险的亲属(经患者同意):澳大利亚公众的看法。
Eur J Hum Genet. 2024 Jan;32(1):98-108. doi: 10.1038/s41431-023-01395-9. Epub 2023 Jun 6.
7
Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment.家族性高胆固醇血症的基因检测:卫生技术评估。
Ont Health Technol Assess Ser. 2022 Aug 23;22(3):1-155. eCollection 2022.
8
The Impact of Proband Indication for Genetic Testing on the Uptake of Cascade Testing Among Relatives.先证者基因检测指征对亲属级联检测接受度的影响。
Front Genet. 2022 Jun 16;13:867226. doi: 10.3389/fgene.2022.867226. eCollection 2022.
9
Barriers and facilitators for cascade testing in genetic conditions: a systematic review.遗传疾病级联检测的障碍和促进因素:系统评价。
Eur J Hum Genet. 2020 Dec;28(12):1631-1644. doi: 10.1038/s41431-020-00725-5. Epub 2020 Sep 18.
10
New Case Detection by Cascade Testing in Familial Hypercholesterolemia: A Systematic Review of the Literature.家族性高胆固醇血症中级联检测的新病例检出:文献系统评价。
Circ Genom Precis Med. 2019 Nov;12(11):e002723. doi: 10.1161/CIRCGEN.119.002723. Epub 2019 Oct 22.